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Abstract: Smart antimicrobial surfaces are a powerful tool to prevent bacterial colonisation at 
surfaces. In this work, we report a successful strategy for the functionalisation of 
polydimethylsiloxane (PDMS) surfaces, widely used in medical devices, with salicylic acid 
(SA), a biocide approved for use in humans. Antimicrobial PDMS surfaces were fabricated via a 
rational design in which bi-functional silane linker molecules were covalently grafted onto the 
PDMS via one end, while generating soft intermolecular interactions with SA at the other end to 
enable reversible load-release of the biocide.  A molecular level understanding of the interface 
was obtained using ATR-FTIR, Raman and X-ray Photoelectron spectroscopies, alongside 
Density Functional Theory. These reveal that the linker molecules dock the SA molecules at the 
surface via a 1:1 complexation interaction. Furthermore, each 1:1 complex acts as a nucleation 
point onto which multiple stacks of the biocide are subsequently stabilised via a combination of 
H-bonding and π-π stacking interactions, thus significantly enhancing SA uptake at the interface. 
The use of soft H-bonding and  interactions to create a reservoir of SA molecules at the 
PDMS surface is also inherently important in enabling the subsequent release of SA from the 
interface in order to deliver the antimicrobial effect. The antimicrobial activity of these surfaces 
against model Gram-positive and Gram-negative bacteria represented by E. coli, S. aureus and S. 
epidermidis is demonstrated by a log 6 reduction of planktonic bacterial populations and an 
efficient anti-biofilm activity at the surface.  
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1. Introduction 
Bacterial infections on medical devices account for 60-70% of hospital acquired infections 
worldwide,1 having a critical impact on the use of antibiotics and on the emergence of 
antimicrobial resistance.2 After initial colonisation of surfaces, bacterial communities undergo 
changes in metabolic activity that may lead to the formation of multicellular structures known as 
biofilms.3,4 These biofilms are often resilient and resistant against antibiotics, and constitute one 
of the major causes for medical device failure.5 Despite the improvement of aseptic practises, 
bacterial contamination on medical devices cannot be avoided, given that the human body 
contains one bacterial cell per each human cell,6 distributed across the skin, the oral mucosa, and 
the gastrointestinal track. In this context, the use of intrinsically antimicrobial surfaces provides 
an important route to tackle the issue at source.  
A key strategy to prevent biofilm formation on medical devices is using biocide-releasing 
antibacterial coatings.7–9 However, two major innovation challenges need to be considered: First, 
the modification of medical device materials may encounter strong biocide regulatory barriers, 
thus requiring strategies that utilise approved chemical agents. Second, there is a need to 
minimise the impact on existing manufacturing processes and avoid the prohibitive economic 
costs of replacing mass production facilities. Thus, there is a need to create approaches that may 
be inserted into the manufacturing processes with minimal impact. 
Here, we show that a molecular-level design of operational interfaces can deliver antibacterial 
function directly at the surface of medical devices. We focus on the design of antimicrobial 
PDMS surfaces using salicylic acid (SA), a commonly used biocide. PDMS is widely used for 
manufacturing medical devices, with applications including voice prostheses, 10 venous 11 and 
urinary catheters.12 Salicylic acid is approved for use in humans, with a broad mechanism of 
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action on different bacterial species,13–15 making it a good candidate for delivering anti-biofilm 
properties to a PDMS surface.  
In this work, we present a rational design to functionalise PDMS surfaces with SA exploiting 
specific chemical interactions between salicylic acid and amino/imidazoline silane molecules 
covalently anchored to PDMS. These anchoring moieties are able to promote enhanced loading 
and release of the biocide from the functional PDMS surfaces. The antimicrobial activity of these 
surfaces against model Gram-positive and Gram-negative bacteria is demonstrated by a log 6 
reduction of planktonic bacterial populations and an efficient anti-biofilm activity at the surface. 
Importantly, surface-sensitive spectroscopies and density functional theory calculations enable a 
molecular-level understanding of the interactions that deliver the antibacterial performance.  
  
 5 
2. Results and discussion 
2.1 Fabrication and characterisation of PDMS surfaces functionalised with salicylic Acid 
An effective antibacterial PDMS material must possess the ability to load and release the 
biocide from its surface and it is, therefore, important that the intermolecular interactions at the 
functional interface are tailored to deliver this function. Functional PDMS surfaces were 
fabricated via a generic approach summarised in Figure 1 in which tailored molecules were used 
as linkers between the PDMS and the SA biocide (see experimental section for details). The 
linker molecules were chosen to be bifunctional so that they could be directly grafted onto the 
PDMS using robust covalent chemistry via one end, while inducing softer intermolecular 
interactions with SA via the other end to enable reversible load-release of the biocide.  
A number of functionalised surfaces were created via this step-wise chemical modification, 
Figure 1. In each case, cured PDMS surfaces were plasma cleaned, prior to functionalisation, to 
remove organic contaminants at the surface. The impact of each modification step on the 
interface was evaluated using a combination of ATR-FTIR, Raman and X-ray photoelectron 
(XPS) spectroscopies. 
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Figure 1. Sequential fabrication of the antibacterial surfaces: (a) PDMS surface (PDMS) (b) 
exposed to salicylic acid (PDMS-SA); PDMS surface functionalised with (c) APTES linker 
molecule (APTES) and (d) subsequently loaded with salicylic acid (APTES-SA); PDMS surface 
functionalised with (e) IPTES linker molecule (IPTES) and (f) subsequently loaded with salicylic 
acid (IPTES-SA). 
 
A simple approach would be to introduce the SA biocide by directly exposing the molecule to 
the PDMS surface (Figure 1a and 1b). However, this strategy was unsuccessful with ATR-IR and 
Raman spectroscopy unable to detect the vibrational bands of SA in the PDMS-SA samples 
(Figure 2a and 2d). These data suggest that negligible loading of SA is achieved using this 
approach. We, therefore, created PDMS-Linker-Biocide interfaces, in which linker molecules 3-
aminopropyl triethoxysilane (APTES) and 3-(2-Imidazolin-1-yl) propyl triethoxysilane (IPTES) 
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were incorporated to deliver a dual function at the interfaces. The first function of robust 
immobilisation onto PDMS was achieved via covalent coupling, exploiting the triethoxysilane 
functionality to create strong interfacial Si-O bonds. The second function dealt with the efficient 
loading and release of SA at the interface and was delivered specifically by the amino and the 
imidazoline functionalities, exploiting their ability to interact with aromatic carboxylic acids via 
soft H-bonding and - interactions. The functionalisation with linker molecules, 3-aminopropyl 
triethoxysilane (APTES) and 3-(2-Imidazolin-1-yl) propyl triethoxysilane (IPTES) produced the 
‘APTES’ and ‘IPTES’ surfaces, respectively. These surfaces were subsequently exposed to 
salicylic acid to yield ‘APTES-SA’ and ‘IPTES-SA’ surfaces, as shown schematically in 
Figure 1.   
 
Both APTES-SA and IPTES-SA samples displayed vibrational signatures associated with 
salicylic acid, underlining the importance of these linker molecules in loading SA onto the 
PDMS surface. Distinct IR bands appear at 1486 cm-1 and 1456cm-1 related to the stretching 
vibrational modes of the aromatic ring in SA.16,17, (Figure 2b and 2c). Raman bands attributed to 
in-plane bending vibrations of the SA phenolic ring at 1143 cm-1 and 1032 cm-1 were also 
observed (Figure 2e and 2f). 16,17 The vibrational spectroscopy data also provided insights into 
the chemical nature of SA at the PDMS interface. Specifically, the absence of the strong 
carbonyl stretching band between 1650-1700 cm-1, along with the presence of the symmetric 
stretching of the carboxylate group at 1386 cm-1,18 were consistent with the formation of 
salicylate species at the interface (Figure 2b and 2c). 
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Figure 2. ATR-FTIR (a-c) and Raman (d-f) spectra of PDMS surfaces before and after loading 
of salicylic acid: (a,c) PDMS and PDMS-SA, (b,d) APTES functionalised PDMS (APTES and 
APTES-SA), (c,f) imidazoline functionalised PDMS (IPTES and IPTES-SA). Black and red 
spectra correspond to the substrates before and after salicylic acid functionalisation, respectively. 
Red arrows show salicylic acid bands observed after loading. Additional spectra for salicylic acid 
(Figure S1 and Figure S2) and functionalised PDMS surfaces (Figure S3 and Figure S4) can be 
found in supplementary information. 
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Spatial distribution of Salicylic Acid across functionalised PDMS surfaces 
We investigated the distribution of SA within the PDMS substrate using confocal Raman 
spectroscopy. The Raman cross-section data revealed a preferential localisation of SA at the 
interface of APTES and IPTES functionalised PDMS samples (Figure 3, and Figure S5). 
Distribution along the depth cross-section was monitored exploiting the Raman peak of SA at 
1032 cm-1, which lies in a spectral region clear from PDMS peaks.  The SA mapping across the 
PDMS-air interface demonstrated that in the presence of silane functionalisation, SA was loaded 
~ 500 microns into the PDMS substrates, showing a rapid decrease in SA concentration as the 
depth increased. Again, the Raman fingerprint for SA was not observed for the PDMS-SA 
system, which does not include the silane functionalisation. These experimental results 
confirmed that the linker silane molecules are key for enhancing the loading capacity of PDMS, 
creating a reservoir of SA at the interface that can be exploited for controlled release of the 
biocide. 
 
Figure 3. Representative Confocal Raman Spectroscopy cross-section profiles of salicylic acid 
distribution within different control and silanised surfaces, before and after salicylic acid 
loading: (a) PDMS and PDMS-SA, (b) APTES and APTES-SA, (c) IPTES and IPTES-SA. 
Black and red plots correspond to experimental data points from the substrates before and after 
functionalisation with salicylic acid, respectively. Blue dashed lines indicate experimental 
detection limit. 
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2.1 Intermolecular interactions governing the PDMS-Linker-Salicylic Acid interface. 
The molecular interactions underpinning the incorporation of SA on APTES and IPTES 
functionalised surfaces were probed using X-ray Photoelectron Spectroscopy (XPS) and Density 
Functional Theory (DFT). The N 1s region of the XPS was the most informative since it 
provided information specifically related to the interface and free from signals arising from the 
PDMS substrate. Density Functional Theory (DFT) calculations were performed using the M06-
2X functional combined with 6-311++G(d,p) basis set, which can accurately describe hydrogen 
bonding and π-π dispersion forces.19 We detail below the insights gained for both the APTES-SA 
and IPTES-SA interfaces. 
 
APTES-SA interfaces 
Figure 4a shows the XPS data from the N 1s peaks for the APTES and the APTES-SA 
interfaces. Essentially, the N 1s peak tracks the behaviour of the APTES molecule since this is 
the only entity to possess nitrogen atoms within the working interface. The N 1s peak can be 
deconvoluted into contributions arising from the free amine (~399 eV), the H-bonded NH2 group 
(~ 401 eV), and the protonated NH3
+ group (~402 eV). XPS N 1s data of the APTES samples, 
Figure 4a, show that up to 62% of nitrogen atoms were present as free amines, with the rest 
existing as H-bonded and protonated amino groups, attributed to intermolecular NH2-NH2 
interactions within the APTES layer.20 Following exposure to SA, this ratio was reversed, with 
the APTES-SA surfaces displaying 77% of the amines in the protonated form. These results are 
consistent with the pKa values for APTES and SA (see Table S2). 
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Figure 4. (a) XPS of the N 1s region of APTES and APTES-SA samples, showing an increase in 
protonated N atoms after functionalisation with salicylic acid (SA). (b,c) DFT calculations of 
intermolecular interactions occurring at APTES-SA interfaces: APTES-salicylic acid 
interactions: (I) Strong H-bonding/Proton transfer. Salicylic acid-salicylic acid interactions: (IIA, 
IIIA) Parallel π-π stacking; (IIB) anti-parallel π-π stacking; (IIIB) intermolecular hydrogen-
bonding. Additional XPS data is presented in SI. 
 
Density Functional Theory (DFT) calculations provide further information into the nature of 
the SA-APTES interaction. One of the most important insights is that a variety of interactions are 
energetically favourable and that they can be realised in both 1:1 and 1:n APTES:SA ensembles. 
 12 
Figure 4 shows the most favourable interactions that arise for 1:1, 1:2 and 1:3 clusters. For the 
1:1 dimer, the preferred interaction is via strong proton-sharing between the carboxylic group of 
salicylic acid and the amino group of APTES, with salicylic acid acting as proton donor, leading 
to an energy stabilisation of nearly 19 kcal/mol (Interaction I, Figure 4b and 4c). This APTES-
SA proton-sharing interaction is significantly stronger than the hydrogen bonding between SA or 
between water molecules, as indicated by a shorter O···H bond distance and a higher binding 
energy for the formation of APTES-SA dimer (Table 1).  
 
Table 1. Calculated hydrogen bond energies (EHB), intermolecular O···H bond distance (dHB), 
and O···H–O bond angle (HB) for different molecular dimers (SA: salicylic acid). 
Molecular 
dimer 
EHB 
(kcal/mol) 
dHB (Å) HB 
water-water* -5.8 1.99 172.6 
SA-SA** -8.7 1.67 179.1 
IPTES-SA -15.5 1.62 178.7 
APTES-SA -18.8 1.62 168.6 
* water dimer data included for comparison 21 
** for SA-SA dimer EHB is normalised, considering two intermolecular hydrogen bonds
. 
 
Another important insight from the DFT calculations is that the APTES:SA dimer acts as a 
nucleation point which enables additional SA molecules to be loaded using a variety of 
intermolecular SA-SA interactions (Figure S10). For example, in the 1:2 cluster, π-π stacking 
forces enable parallel (Interaction IIA) and anti-parallel (Interaction IIB) SA-SA stacks to be 
generated, each bringing an energy stabilisation of ~10 kcal/mol. In the 1:3 ensemble, additional 
SA molecules can be docked along one direction via further π-π stacking (Interaction IIIA) or 
along the other direction via frontal inter-molecular hydrogen bonding (Interaction IIIB), with 
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significant energy stabilisation of ~11 and ~18 kcal/mol, respectively. The DFT calculations 
reveal that the chemical structure of the APTES is a key enabler in immobilising the first layer of 
SA molecules to the PDMS surface, while the inherent chemical structure of SA can exploit a 
range of intermolecular interactions to create multilayer supramolecular structures22 with 
considerable energy stabilisation. The interactions between SA molecules contributed 
substantially to the stability of the 1:n calculated supramolecular structures shown in Figure 4b-c 
and, importantly, suggests that several SA molecules can be anchored to one single APTES 
moiety where, in principle, n could reach high values.   
 
IPTES-SA interfaces 
DFT results obtained for the IPTES-SA system display a similar picture (Figure 5b-d and 
Figure S11). In this case, IPTES is also capable of π-π interactions, adding further complexity to 
the supramolecular structures. Thus, for the 1:1 dimer structure of IPTES-SA, two distinct 
configurations can be proposed: (a) frontal hydrogen-bonding with co-planar geometry of SA 
and IPTES rings (Interaction IA) or (b) π-π stacking of the IPTES and SA aromatic systems 
(Interaction IC). As for the APTES system, the 1:2 and 1:3 families of supramolecular structures 
can be obtained by adding multiple SA molecules to the 1:1 dimer (Figure 5b-d) and are 
stabilised by additional energy contributions from π-π interactions (Interaction IIA, IIB, IIIA, IIIC) 
or H-bonding (Interaction IIIB, IIC), again underlying the role of a single IPTES linker group to 
nucleate the docking of several salicylic acid molecules.   
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Figure 5. (a) XPS of the N 1s region of IPTES and IPTES-SA samples, showing an increase in 
protonated N atoms after functionalisation with salicylic acid (SA). (b-d) DFT calculations of 
intermolecular interactions occurring at IPTES-SA interfaces: IPTES-salicylic acid interactions: 
(IA) hydrogen-bonding; (IC) π-π stacking. Salicylic acid-salicylic acid interactions: (IIA, IIB, IIIA, 
IIIC) π-π interactions; (IIC, IIIB) hydrogen-bonding. Additional XPS data is presented in SI. 
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The N1s XPS data for IPTES-SA samples (Figure 5a) show that the N 1s binding energy upshifts 
from 400.6 to 401 eV upon introduction of the SA and has a value intermediate between that of a 
free amine (~399 eV) and a protonated amine (~402 eV). This is consistent with the DFT 
calculations, which show that the IPTES-SA H-bonding is weaker than in APTES-SA, leading to 
lower energy stabilisation (Table 1).  
Our DFT calculations for both APTES-SA and IPTES-SA systems showed that the linker 
molecules play a pivotal role in docking the first layer of SA molecules to the interface via 1:1 
dimers, with an energy stabilisation that can range from ~10 kcal/mol to ~18 kcal/mol. 
Importantly, these 1:1 dimers promote the docking of further SA molecule at the interface via the 
formation of a range of complex supramolecular structures in which different bonding modes 
coexist, creating a local reservoir of SA at the interface.  
 
2.2 Antimicrobial activity of PDMS surfaces functionalised with Salicylic Acid  
Release of salicylic acid into aqueous medium 
The release of SA from the PDMS surfaces into aqueous medium was evaluated using UV-
visible spectroscopy. For this purpose, a model pH buffer based on sodium citrate was optimised 
to provide optical transparency in the UV region of interest for SA determination, and to 
resemble the pH response of physiological media typical for biological assays (Figure S12). 
Under these model buffer conditions, the concentration of SA released after 24h from APTES-
SA and IPTES-SA modified PDMS reached 1.46 (± 0.36) mg mL-1 and 1.06 (± 0.14) mg mL-1, 
respectively. PDMS-SA gave a considerably lower SA release of 0.31 (± 0.13) mg mL-1 after 24 
h, consistent with the significantly reduced loading of SA in these systems. These results also 
demonstrate that the increased quantities of salicylic acid that can be loaded into silane modified 
PDMS can be effectively released under physiological conditions. 
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Effect on planktonic bacteria. 
The antimicrobial activity of SA functionalised surfaces against planktonic bacteria was 
evaluated by measuring the concentration of viable cells in the liquid media in contact with the 
surfaces, over a period of 24 h. Figure 6 shows the planktonic colony forming unit (CFU) 
concentrations for three model bacterial species exposed to control and SA modified PDMS 
surfaces. This data showed that the initial modification of PDMS with either APTES or IPTES 
silane molecules had no significant effect on the viability of planktonic bacteria, leading to CFU 
values close to the unmodified PDMS surface. However, for both the APTES-SA and IPTES-SA 
systems, we observed a drastic reduction of CFU after 24 h of exposure and the plate counting 
did not reveal viable CFUs. This demonstrates the effectiveness of SA-linker-PDMS interfaces 
to exert a strong antimicrobial effect on the surrounding environment. 
 
Figure 6. Planktonic viability for E. coli (green), S. aureus (red), and S. epidermidis (blue) after 
24 h of incubation onto plasma cleaned PDMS, PDMS surface exposed to salicylic acid (PDMS-
SA), APTES functionalised surface (APTES), APTES coated surface loaded with salicylic acid 
(APTES-SA), IPTES functionalised surface (IPTES) and IPTES coated surface loaded with 
salicylic acid (IPTES-SA). *Below the detection limit of 1.5x102 CFU mL-1. 
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The observed antimicrobial effect can be directly correlated to the concentration of biocide 
released from the surfaces as compared to the minimum inhibitory concentration (MIC) and the 
minimum bactericidal concentration (MBC) of SA against the bacterial strains used (Table 2).   
Table 2. Minimum inhibitory concentration (MIC) and Minimum Biocidal Concentration 
(MBC) for salicylic acid against the bacterial species investigated. 
 MIC (mg mL-1) MBC (mg mL-1) 
E. coli 0.75 0.75 
S. aureus 0.56 0.75 
S. epidermidis 0.42 0.56 
 
Both the APTES-SA and IPTES-SA systems release a higher concentration of SA than the 
MIC and the MBC for all three microorganisms, thus delivering a strong antimicrobial effect 
(>log 6 reduction of CFU respect to a control). In contrast, the release of SA from PDMS-SA is 
below the MICs and, therefore, there is no significant reduction in the planktonic bacteria 
compared to the control samples.  
 
We noted that the final pH values for the MBC solutions in the culture media were 
considerably lower than the starting pH of the growing media, due to the weak-acidic nature of 
SA. However, the biocidal action of SA cannot be only attributed to the change in pH, since all 
three bacterial strains were able to grow in nutrient broth solutions acidified with hydrochloric 
acid to the same pH values (Figure S13). We can, therefore, conclude that, under our 
experimental conditions, released SA from silane functionalised samples delivered an effective 
biocidal effect against planktonic cells. 
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Effect on surface attached bacteria. 
Surface-attached bacteria, forming biofilms, tend to be more resistant to the action of 
biocides.23,24 We, therefore, also evaluated the viability and density of bacteria directly attached 
to the PDMS surfaces using confocal laser scanning microscopy (CLSM) and scanning electron 
microscopy (SEM). Large area, low magnification SEM images show a significant reduction in 
the number of bacterial cells on APTES-SA and IPTES-SA surfaces, compared to control PDMS 
and silane functionalised PDMS samples (Figure 7). Live/Dead CLSM imaging enabled the 
viability of the surface attached cells to be quantitatively evaluated (Figure 8 and Figure 9).   
 
First, we note that the behaviour of the APTES and IPTES surfaces indicate that the presence 
of the silane linker molecules at the surface has a minor effect on the sessile cells that is species 
dependent. The number and viability of S. aureus is unaffected by either the APTES or the 
IPTES surfaces. E. coli is largely unaffected by the IPTES surface, but the number and viability 
are slightly compromised the APTES surface. Finally, S. epidermidis viability is reduced on both 
APTES and IPTES surfaces. Molecules containing protonable amines and imidazoline groups 
have been previously shown to damage bacterial cellular membranes.25,26 We note, however, the 
effects of the APTES and IPTES surfaces are relatively small compared to the antimicrobial 
performance in the presence of the SA functionalisation. 
 
The combined data set shows that when both silane-modified surfaces were loaded with SA, a 
dramatic reduction in both the density and viability of sessile bacteria is observed (Figure 7-9).  
Both APTES-SA and IPTES-SA surfaces show a dead fraction of up to ~90% for all three 
bacterial strains. The biocidal effect shows no distinction between Gram-negative and Gram-
positive bacteria, demonstrating a wide spectrum activity. This data, combined with the results 
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obtained on the experiments for planktonic cells, demonstrates that the PDMS-Linker-SA 
surfaces display significant antibacterial activity against both planktonic and sessile bacteria. 
 
Figure 7. Representative low-magnification (x500) scanning electron microscopy images of 
surface attached bacteria on PDMS, APTES and IPTES samples with and without SA loading. 
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Figure 8. Representative confocal laser scanning microscopy images for live/dead staining with 
Syto9 (green) and propidium iodide (red) for bacteria attached to PDMS, APTES, APTES-SA, 
IPTES and IPTES-SA surfaces. By column: E. coli, S. aureus and S. epidermidis. 
IP
TE
S-
SA
IP
TE
S
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Figure 9. Viability of surface attached E. coli (green), S. aureus (red), and S. epidermidis (blue) 
after 24 h of incubation on pristine and functionalised PDMS surfaces. 
High magnification SEM imaging was used to probe the antimicrobial effect of the surfaces at 
the single-cell level. Overall, cell morphology seems to remain unaffected by the presence of the 
silane linkers only at the APTES and IPTES surfaces in the absence of SA. However, this 
situation changes drastically when SA is introduced to the interface, with the morphology of the 
bacterial cell envelopes being heavily compromised on APTES-SA and IPTES-SA surfaces 
(Figure 10 and Figure S14). For example, the rod-shaped E. coli cells display a loss of their 
integrity predominantly at the polar ends. For S. aureus and S. epidermidis, there is loss of 
spherical symmetry, with considerable increase of roughness and/or collapse of the cell wall. 
These results suggest that the mode of action of SA involves destabilisation of the membrane 
integrity and subsequent disruption of cell envelope, as previously reported.27 These results were 
systematically observed for both APTES-SA and IPTES-SA surfaces, confirming that the two 
silane functionalities act as effective interfacial dockers and carriers for the biocide, which upon 
release compromises the viability of colonising bacteria. The remarkable reduction of the 
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number and viability of sessile bacteria demonstrates that the surfaces developed herein are 
effective for prevention of bacterial biofilms.  
 
Figure 10. Representative high-magnification (x20,000) scanning electron microscopy images of 
surface attached bacteria on pristine PDMS, APTES, APTES salicylic acid (APTES-SA) 
functionalised, IPTES and IPTES salicylic acid (IPTES-SA) functionalised PDMS surfaces. 
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3. Conclusion 
Antibacterial PDMS surfaces were created via a generic strategy that exploited bi-functional 
silane linker molecules to create PDMS-Linker-Biocide interfaces. Specifically, the 
triethoxysilane functionality was used to graft one end of the linker onto the PDMS via the 
creation of strong covalent Si-O bonds, while the other end displayed amino or imidazoline 
functionalities to dock salicylic acid molecules via soft H-bonding and - interactions. The 
molecular interactions within this three-component interface were investigated by 
complementary spectroscopic techniques (FTIR, Raman and X-ray Photoelectron 
Spectroscopies) and DFT calculations. These data show that the uptake of SA at the interface 
occurs via two steps. First, each linker molecule attracts a single SA molecule to create a 1:1 
linker:SA dimer held together by soft interactions and providing significant energy stabilisation. 
Subsequently, each 1:1 complex provides a nucleation point that attracts further biocide 
molecules via the stabilisation of supramolecular SA structures held together by H-bonding and 
stacking interactions. This enables a single linker molecule to attract multiple SA molecules, 
thus significantly enhancing biocide uptake at the interface. Importantly, the use of soft H-
bonding and  interactions to create a reservoir of SA molecules at the PDMS surface is also 
important in delivering the ability to subsequently release the SA into the environment or to 
attached bacterial species in order to deliver the antimicrobial effect. 
Antibacterial properties of the modified PDMS surfaces were tested against sessile and 
planktonic E. coli, S. aureus and S. epidermidis cells. Both APTES-SA and IPTES-SA surfaces 
reduced the number of viable bacteria in the planktonic state to values under the detection limit 
for the CFU assay. The viability and morphology of persistent sessile bacteria were assessed 
using Live/dead staining, laser scanning microscopy and scanning electron microscopy. These 
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data showed that the density of sessile bacterial cells was considerably reduced on APTES-SA 
and IPTES-SA surfaces and that the morphology of the attached bacteria was heavily 
compromised leading to a dead fraction of up to 90%.  The biocidal effect was present for both 
Gram-negative and Gram-positive bacteria, demonstrating a wide spectrum activity. Finally, the 
simple two-step functionalisation approach is easily translated to the manufacture of 
antimicrobial medical devices to prevent surface colonisation and systemic infections by Gram-
positive and Gram-negative bacteria. 
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4. Experimental Section  
Synthesis and chemical characterisation of PDMS surfaces 
Fabrication of PDMS substrates: PDMS (Sylgard 184 silicone elastomer kit, Dow Corning) 
was mixed at 10:1 base to curing agent ratio. The two components were thoroughly mixed and 
degassed under vacuum for 25 min to remove trapped air bubbles. The mixture was poured into 
individual wells of 24-well plates and heat-cured at 70 °C for 5 h. The surface area of each 
PDMS substrate was determined by the diameter of each individual well (~ 188 mm2), while the 
thickness (~19.4 ± 0.31 mm) was reproduced within a 15% of deviation. 
Functionalisation of PDMS surfaces: PDMS substrates underwent a two-step surface 
modification process, which resulted in six different surface types. First, all PDMS surfaces were 
cleaned using a Zepto plasma cleaning system (Diener Electronic GmBH) applying 20 W 
radiofrequency power at 40 kHz for 1 min at 0.3 mbar constant air pressure. This step also 
ensured the presence of reactive SiO2 at the surface of PDMS,
28 enabling further 
functionalisation with silane molecules. PDMS-linker surfaces were created by immersion in 
10% (v/v) ethanolic solutions of (3-aminopropyl) triethoxysilane (APTES, Fluorochem) or 3-(2-
Imidazolin-1-yl) propyl triethoxysilane (IPTES, Fluorochem) for 2 h at 50 °C. Samples were 
rinsed three times with ethanol to remove physisorbed silane molecules and dried at room 
temperature. The silanisation process was used to fabricate APTES and IPTES surfaces, by 
introducing amine and imidazoline functional groups at the surface, respectively. Assuming a 
complete monolayer of silane molecules,29 we estimated a surface coverage of at least 2×1014 
molecules/cm2. Subsequently, PDMS, APTES and IPTES were immersed for 20 h in a 200 mM 
salicylic acid solution in 50/50 ethanol/water, and repeatedly washed with DI water and ethanol 
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to obtain PDMS-SA, APTES-SA and IPTES-SA surfaces, respectively. Details of the chemical 
compounds used for surface functionalisation are included in Table S2. 
Chemical Characterisation of PDMS surfaces: Pristine and modified PDMS surfaces were 
investigated by attenuated total reflectance – Fourier transform infrared (ATR-FTIR), X-ray 
photoelectron spectroscopy (XPS) and Raman spectroscopy. Infrared measurements were 
performed using a Bruker Alpha FT-IR with Platinum ATR module with a resolution of 4cm-1. 
Each spectrum was the average of 24 scans. Sample spectra were collected in the 400-4000 cm-1 
range and analysed using OPUS Spectroscopy Software (Bruker).  
The surface Raman spectra were recorded with a Renishaw inVia Confocal Raman microscope 
using an excitation wavelength of 532 nm at 50% power and a 20x objective lens, with 8 seconds 
acquisition time. Raman spectra were processed using WiRE 4.4 software (Renishaw). 
XPS data of pristine and modified PDMS surfaces were recorded on a Kratos Axis Supra 
instrument using monochromatic Al Kα radiation (1486.7 eV, 150 W). Survey scan spectra were 
acquired using a pass energy of 160 eV and a 1 eV step size. Narrow region scans of C 1s and N 
1s were acquired using a pass energy of 20 eV and a 0.1 eV step size. A charge neutraliser was 
used to compensate the electrically insulating nature of the samples. The spectra were calibrated 
post acquisition to the binding energy of 285.0 eV for the hydrocarbon C 1s peak. Data was 
processed and analysed using CasaXPS and Kratos ESCApe software (Kratos). 
Raman spectroscopy of PDMS cross-sections: Modified PDMS substrates were cut 
transversally and the cross-sections of the samples were spectroscopically examined using a 
Renishaw inVia Confocal Raman microscope. The Raman spectra of the modified PDMS 
samples were obtained using a map image acquisition mode, sampling every 10 µm starting from 
the top of the surface (xo=0 µm) to a distance equivalent to 1 mm within the material (xf=1000 
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µm). For each measurement, an excitation wavelength of 532 nm and a 50% power were 
selected, using a 20x Leica objective lens and 8 seconds acquisition time. The Wire 4.4 analysis 
software (Renishaw) allowed correction of the baseline for each individual spectrum. The 
distribution of salicylic acid through the sample cross-section was monitored measuring the 
intensity of the Raman band at 1032 cm-1. The intensity of the band at 1032 cm-1 was obtained 
by determining the baseline corrected peak intensity from 1020 to 1045 cm-1. Cross-section data 
points below the experimental detection limit were set to zero. 
Salicylic acid release from modified PDMS: The release of salicylic acid from PDMS-SA, 
APTES-SA and IPTES-SA surfaces was evaluated by UV-VIS spectrophotometry measuring the 
absorbance at 299 nm. The volume/surface ratio and the temperature were adjusted to reproduce 
the conditions of the biological assays, using 750 μL of pH 7 citrate model buffer and incubating 
the samples for 24 h at 37 oC. The citrate model buffer replaced the nutrient broth (NB) used in 
the bacterial viability experiments, since NB is not transparent in the UV-VIS region of interest. 
The model buffer was prepared by dissolving specific amounts of sodium citrate (Sigma Aldrich) 
and citric acid (Sigma Aldrich) in DI water to produce a pH 4.8 10 mM citrate buffer solution. 
The final pH of this model buffer was adjusted to pH 7 using a 1 M sodium hydroxide solution 
(Sigma Aldrich). 
Theoretical Methods 
Density functional theory calculations: Density functional theory (DFT) calculations were 
performed with the Gaussian 09 program30 using M06-2X functional combined with 6-
311++G(d,p) basis set. Geometry optimisations were performed until forces and displacements 
were below reasonable thresholds and frequency calculations were performed to ensure minima. 
Interaction energies were computed using the following equation 
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𝐸int = 𝐸𝑀𝑜𝑙1+𝑀𝑜𝑙2 − 𝐸𝑀𝑜𝑙1 − 𝐸𝑀𝑜𝑙2 
Where Mol1 and Mol2 are the individual components and Mol1+Mol2 represents the complex 
or dimeric structure. For example, in the APTES-SA system, Mol1 is the amino group of APTES 
and Mol2 is the salicylic acid (SA) molecule, and Mol1+Mol2 is the dimer APTES-SA. In cases 
where multiple salicylic acid molecules were considered, Mol1+Mol2 was the APTES/IPTES-
(n+1)SA complex, Mol1 was the salicylic acid molecule and Mol2 was the APTES/IPTES-(n)SA 
complex; this enabled us to evaluate the individual contribution of each additional salicylic acid 
and, therefore, the potential for multi-stacking of salicylic acid molecules. Evaluation of the 
potential energy landscape for π- π stacked SA-SA and IPTES-SA dimers was performed 
imposing constrains to selected dihedrals (composed of two atoms from each ring) and scanning 
the full angular range (0-360o).  Geometry optimisations were performed for each point in the 
dihedral scans and the lowest energy configurations were selected for unconstrained geometry 
optimizations.  Further selections of initial conformations were based on chemical intuition, 
testing a large number of viable conformations, and reporting lowest energy geometries. 
 
Antibacterial performance of modified PDMS surfaces 
Viability of planktonic bacteria: Escherichia coli (ATCC 10798), Staphylococcus aureus 
(DSM 346) and Staphylococcus epidermidis (ATCC 12228) were transferred from the stock to a 
fresh agar plate and incubated overnight at 37 °C. Three colonies of each species were taken 
from the agar plate, transferred to fresh nutrient broth (NB) medium (Oxoid, Ltd-Thermo Fisher) 
and grown overnight in a shaking incubator (200 rpm, at 37 °C). The bacterial cell concentration 
was adjusted to 105 colony forming units per millilitre (CFU mL-1) in sterile NB for each of the 
bacterial strains. Modified PDMS surfaces were sterilised with UV light for 20 min and placed in 
a sterile 24-well plate. Then, 750 μL of 105 CFU mL-1 bacterial suspension in NB were added to 
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each of the wells and the plates were incubated for 24 h at 37 °C. At the end of each incubation 
period, serial dilutions of the resulting suspensions were performed to determine the planktonic 
bacterial viability by CFU mL-1 counting. Viability assays of planktonic bacteria were performed 
in triplicate. 
Determination of Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal 
Concentration (MBC): E. coli (ATCC 10798), S. aureus (DSM 346) and S. epidermidis (ATCC 
12228) were grown as stated above. Bacterial cell concentration was adjusted to 105 CFU mL-1 in 
sterile NB for each bacterial strain. Then, 100 μL of the bacterial solution were added to the 
microwells of a sterile 96-well plate containing 100 μL of salicylic acid solutions at different 
concentrations. The plates were placed in a FilterMax F5 Multimode Plate Reader (Molecular 
Devices) and the optical density at 595 nm was screened every 30 min for 24 h at 37°C. The 
MIC was calculated as the minimum salicylic acid concentration that prevented a detectable 
optical density increase. After incubation, the bacterial solutions from the non-growing 
microwells were taken and diluted in fresh NB (2-fold dilution). 20 μL from each solution were 
transferred to a fresh agar plate and incubated for 48 h. The MBC was calculated as the 
minimum concentration that did not show bacterial colonies on the agar plate. 
 
Viability of sessile bacteria: The viability and the density of bacteria attached to the surfaces 
were investigated by fluorescence microscopy and scanning electron microscopy (SEM). In both 
cases, E. coli, S. aureus and S. epidermidis were incubated over pristine or modified PDMS 
surfaces for 24 h, as described in the previous section. For each bacterium, experiments were 
carried out as three independent biological replicates. 
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Prior to confocal fluorescence imaging, functionalised PDMS surfaces were washed 3 times 
with sterile 0.85% (w/w) NaCl solution and stained with Live/dead BacLight Bacterial Viability 
kit (Molecular Probes, L7012). In this test, 1 mL of a sterile 0.85% solution containing mixtures 
of SYTO 9 (green-fluorescent nucleic acid stain for all cells), and propidium iodide (red-
fluorescent nucleic acid stain for dead cells) was added to each sample in a 24-well plate and 
incubated for 15 min in the dark at room temperature. After staining, the surfaces were 
immediately imaged using a confocal upright Zeiss LSM 880 Multiphoton microscope. Images 
were analysed with an in-house script based on Fiji software. 
SEM samples were incubated for 24 h with bacteria and fixed overnight at 4 °C with 4% 
paraformaldehyde and 2.5% glutaraldehyde in 0.1 M phosphate buffer. Sample fixation was 
completed in four sequential steps using 2% osmium tetroxide, 1% tannic acid, 2% osmium 
tetroxide and 1% uranyl acetate solutions in water. Every step was assisted by a Biowave Pro 
Microwave system (Pelco). For each step, samples were exposed to cycles of 100W microwave 
radiation for 20 s and subsequently cooled down for 20 s. This process was repeated three times 
per microwaving step. Between each staining step, the samples were thoroughly rinsed with DI-
water. After the final uranyl acetate staining, the samples were rinsed with DI-water, and 
progressively dehydrated with different volumetric ratios of ethanol (i.e. 30%, 50%, 70%, 80%, 
90% and 100%). After dehydration, modified and control PDMS samples were critical-point 
dried in CO2 (Quorum Technologies K850) and sputter coated with 10 nm of Au/Pd (Quorum 
Technologies Q150T) for SEM imaging at 10 kV using a JEOL SEM 7001 system. 
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Supporting Information  
SI contains additional spectroscopic data on pure salicylic acid and on functionalised surface, 
DFT calculations for the π-π stacked systems, details on the model buffer, biological response at 
acidic pH, and additional SEM images of sessile bacteria. 
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